Simon Latimer | Head, IR |
John Higgins | CEO & Executive Director |
Matthew Korenberg | EVP, Finance & CFO |
Matthew Foehr | President & COO |
Peter Lukas | CJS Securities |
Matthew Hewitt | Craig-Hallum |
Welcome to the Ligand Pharmaceuticals Second Quarter Earnings Conference Call. My name is Vanessa, and I will be your operator for today's call. [Operator Instructions]. Please note that this conference is being recorded. I will now turn the call over to your host, Simon Latimer.